The impending globalization of ADHD: Notes on the expansion and growth of a medicalized disorder

Social Science and Medicine

Volumn 122, Issue , 2014, Pages 31-43

  Conrad, Peter ^a   Bergey, Meredith R ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

ADHD; Diagnosis; DSM; Globalization; ICD; Medicalization

Indexed keywords

GLOBALIZATION; INTERNET; MEDICAL GEOGRAPHY; MENTAL HEALTH; PHARMACEUTICAL INDUSTRY; PUBLIC HEALTH;

ACCESS TO INFORMATION; ARTICLE; ATTENTION DEFICIT DISORDER; BRAZIL; CHECKLIST; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUSTRY; EVIDENCE BASED MEDICINE; FRANCE; GERMANY; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERNET; ITALY; MEDICALIZATION; ONLINE SYSTEM; PREVALENCE; PSYCHIATRIC DIAGNOSIS; UNITED KINGDOM; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD PSYCHIATRY; CONSUMER HEALTH INFORMATION; EUROPE; HEALTH; HEALTH EDUCATION; ORGANIZATION AND MANAGEMENT; PROCEDURES; SOCIAL ENVIRONMENT; TRENDS; UNITED STATES;

BRAZIL; FRANCE; GERMANY; ITALY; UNITED KINGDOM; UNITED STATES;

ADOLESCENT PSYCHIATRY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAZIL; CHILD PSYCHIATRY; CONSUMER HEALTH INFORMATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUSTRY; EUROPE; GLOBAL HEALTH; HEALTH EDUCATION; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERNET; MEDICALIZATION; SOCIAL ENVIRONMENT; UNITED STATES;

EID: 84908457144     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2014.10.019     Document Type: Article

References (148)

1. Abraham John The sociological concomitants of the pharmaceutical Industry and medications. The Handbook of Medical Sociology 2010, Vanderbilt University Press, Nashville TN. C.E. Bird, P. Conrad, A.M. Freemont, S. Timmermans (Eds.).
2. ADHS Deutschland e.v. ADHS bei Kindern und Jugendlichen (Aufmerksamkeits-Defizit-Hyperaktivitats-Storung) 2011, (accessed September 2012). http://www.ag-adhs.de.
3. Agence Nationale de Securite du Medicament et des Produits de Sante Methylphenidate: donnees d'utilisation et de securite d'emploi en France 2013, http://ansm.sante.fr/var/ansm_site/storage/original/application/8dd1277a3867155547b4dce58fc0db00.pdf.
4. Agency for Public Health Document from Agenzia di Sanita' Pubblica', Lazio regarding mental health interventions 2002, (accessed August 2012). http://www.asplazio.it/asp_online/tut_soggetti_deb/files/files_sal_ment/TSMREE_2002.PDF.
5. Akatsu H., Kuffner J. Medicine and the Internet. West. J. Med. 1998, 169:311-317.
6. American Medical Association Physicians Characteristics and Distribution in the U.S. 2008, American Medical Association, Chicago. 2008 ed.
7. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (IV) 1994, American Psychiatric Association, Washington.
8. Anderson J.C. Is childhood hyperactivity a product of western culture. Lancet 1996, 348:73-74.
9. Associazione Italiana Disturbi di Attenzione/Iperattivita) (AIDAI). http://www.aidai.org.
10. Associazione Italiana Famiglie (AIFA). http://www.aifaonlis.it.
11. Ayers S.L., Kronenfeld J.J. Chronic illness and health seeking information on the Internet. Health: Interdiscip. J. Soc. Study Health Illn. Med. 2007, 11(3):327-347.
12. Barbarini Tatana de Andrade Medicalization Through ADHD: Support and Resistance Groups in Brazil July 2014, Paper prepared for the meetings of the International Sociological Association (forthcoming).
13. Barker K. Electronic support groups, patient-consumers, and medicalization: the case of contested illness. J.Health Soc. Behav. 2008, 49:20-36.
14. Barkley R.A. International consensus statement on ADHD. J.Am. Acad. Child Adolesc. Psychiatry 2002, 41(12):1389.
15. Barkley R.A., et al. International consensus statement on ADHD. Clin. Child Fam. Psychol. Rev. 2002, 5(2):89-111.
16. Basaglia F. Conversazione: a proposito della nuova legge 180. dall' apertura del manicomio alla nuova legge sull' assistenza psichiatrica 1982, vol. 2:1968-1980. Turin, Einaudi. F. Basaglia (Ed.).
17. Behague D.P. Psychiatry and politics in Pelotas, Brazil: equivocal quality of conduct disorder and related diagnoses. Med. Anthropol. Q. 2009, 2(4):455-482.
18. Besoli G., Venier D. Il disturbo di attenzione con iperattivita: indagine conoscitiva tra I pediatri di famiglia in Friuli-Venezia Giulia 2003, vol. X:8-9. Quaderni ACP.
19. Bianchini R., Postorino V., Grasso R., Santoro B., Migliore S., Burlo C., Tata C., Mazzone L. Prevalence of ADHD in a sample of Italian students: a population-based study. Res. Dev. Disabil. 2013, 34(9):2543-2550.
20. Bonati M. The Italian Saga of ADHD and its treatment. New Critical Perspectives on ADHD 2005, Routledge, London. G. Lloyd, D. Cohen, J. Stead (Eds.).
21. Bonati M., Impicciatore P., Pandolfini C. Reintroduction of methylphenidate in Italy needs careful monitoring. Br. Med. J. 2001, 322(7285):555.
22. Bonati M., Impacciatore P., Pandolfini C. Evidence and belief in attention deficit hyperactivity disorder: reintroduction of methylphenidate in Italy needs careful monitoring. Br. Med. J. 2001, 322:556.
23. Bramble D. Annotation: the use of psychotropic medications in children: a British view. J.Child Psychol. Psychiatry 2003, 44(2):169-179.
24. Bursztejn C., Golse B. L'hyperactivite avec troubles de l'attention: questions cliniques et epistemologiques. Neuropsychiatrie de l'enfance de l'adolescence 2006, vol. 54:29-37.
25. Canino G., Alegria M. Psychiatric diagnosis - is it universal or relative to culture?. J. Child Psychol. Psychiatry. 2008, 49(3):237-250.
26. Camerini G.B., Coccia M., Caffo E. Il disturbo da deficit dell' attenzione-iperattivita': analisi della frequenza in una popolazione scolastica attraverso questionari agli insegnanti. Psichiatria dell' infanzia e dell' adolescenza 1996, vol. 63:587-594.
27. Care Quality Commission The Safer Management of Controlled Drugs 2013, Annual Report (2012). http://www.cqc.org.uk/sites/default/files/media/documents/cdar_2012.pdf.
28. Carlat D.J. Unhinged: The Trouble with Psychiatry - a Doctor's Revelations about a Profession in Crisis 2010, Free Press, New York.
29. Chambry J. Trouble deficit de l'attention-hyperactivite de l'enfant et l'adolescent: du diagnostic a la prise en charge. Ann. Med. Psychol. 2006, 164:613-619.
30. Clark J. Medicalization of global health 2: the medicalization of global mental health. Glob. Health Action 2014, 7:24000.
31. Clarke A.E., Shim J.K., Mamo L., et al. Biomedicalization: technoscientific transformations of health, illness and U.S. Biomedicine. Am. Sociol. Rev. 2003, 68(2):161-194.
32. Biomedicalization: Technoscience, Health and Illness in the U.S. 2010, Duke University Press, Durham, NC. A.E. Clarke, L. Mamo, J.R. Fosket (Eds.).
33. Clavenna A., Rossi E., Derosa M., Bonati M. Use of psychotropic medications in Italian children and adolescents. Eur. J. Pediatr. 2007, 166:339-347.
34. Cohen R.A., Sussman B. Health Information Technology Use Among Men and Women Aged 18-64: Early Release of Estimates Form the National Health Interview Survey, January-June 2009 2010, (accessed January 2014). http://www.cdc.gov/nchs/data/hestat/healthinfo2009/healthinfo2009.pdf.
35. Conrad P. The discovery of hyperkinesis: notes on the medicalization of deviant behavior. Soc. Probl. Oct. 1975, 12-21.
36. Conrad P. Identifying Hyperactive Children: the Medicalization of Deviant Behavior 1976, DC Heath, Lexington, MA.
37. Conrad P. The shifting engines of medicalization. J.Health Soc. Behav. 2005, 46(March):3-14.
38. Conrad P. The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders 2007, Johns Hopkins University Press, Baltimore.
39. Conrad P. The changing social reality of ADHD. Contemp. Sociol. 2010, 39:525-527.
40. Conrad P. Medicalization: changing contours, characteristics and contexts. Health Sociology on the Move: New Directions in Theory 2013, Blackwell, Oxford. W. Cockerham (Ed.).
41. Conrad P., Potter D. From hyperactive children to ADHD adults: observations on the expansion of medical categories. Soc. Probl. 2000, 47:59-82.
42. Conrad P., Stults C. The Internet and the experience of illness. The Handbook of Medical Sociology 2010, 179-191. Vanderbilt University Press, Nashville TN. sixth ed. C. Bird (Ed.).
43. Corbo S., Marolla F., Sarno V., Torrioli M.G., Vernacotola S. Prevalenza dell'ADHD in bambini sequiti dal Pediatra di Famiglia. Med. Bambino. 2003, 1:22-25.
44. De Souza I., Mattos P., Pina C., Fortes D. ADHD: the impact when it is not diagnosed. J.Braz. Psychiatry 2008, 57(2):139-141.
45. Debroise A. Ritaline: Un Feuilleton à la Française. La Recherche 2004, 16:34-36.
46. Diller L. Running on Ritalin 1997, Bantam Books, New York.
47. Dopfner M., Frolich J., Lehmkuhl G. Hyperkinetische Storungen. Leitfaden Kinder- und Jugendpsychotherapie 2000, Bd 1. Hogrefe, Gottingen.
48. Ebeling M. "Get with the program": pharmaceutical marketing, symptom checklists and self-diagnosis. Soc. Sci. Med. 2011, 73:825-832.
49. Einersdottir J. Teaching children with ADHD: Icelandic early childhood teachers perspectives. Early Child Dev. Care 2008, 178(4):375-397.
50. Eysenbach G., Powell J., Englesakis M., et al. Health related communities and electronic support groups. Br. Med. J. 2004, 328:1166-1170.
51. Faraone S.V., Seargeant J., Gillberg C., Biederman J. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry 2003, 2:104-113.
52. Fayyad J., De Graaf R., Kessler J., et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. BJP 2007, 190:402-409.
53. Ferber L., Schubert I., Lehmkuhl G., Spengler A., Dopfner M. Methylphenidat bei hyperkinetiscen Storungen: Verordnungen in den 90er-Jahren. Dtsch. Arztebl. 2001, 98(9):A-541-A-544.
54. Ferber L., Lehmkuhl G., Koster I., Dopfner M., Schubert I., Frolich J., Ihle P. Methylphenidatgebrauch in Deutschland: Versichertenbezogene epidemiologische Studie uber die Entwicklung von 1998 vis 2000. Dtsch. Arztebl. 2003, 100(1-2):A-41-46.
55. Fox S. Health Information Online. Pew Internet and American Life Project 2005, (accessed January 2014). http://www.pewinternet.org/%7E/media/Files/Reports/2005/PIP_Healthtopics_May05.pdf.
56. Fox S., Fallows D. Internet Health Resources. Pew Internet and American Life Project 2003, Retrieved September 5, 2012. http://www.pewinternet.org/%7E/media//Files/Reports/2003/PIP_Health_Report_July_2003.pdf.pdf.
57. Frances C., Hoizey G., Millart H., Trenque T. Paediatric methylphenidate (Ritalin) restrictive conditions of prescription in France. Br. J. Clin. Pharmacol. 2004, 57(1):115-116.
58. Frazzetto G., Keenan S., Singh I. 'I Bambini e le Droghe': the Right to Ritalin vs the Right to Childhood in Italy. BioSocieties 2007, 2:393-412.
59. Friedman T. The World is Flat: a Brief History of the Twenty-first Century 2005, Farrar, Straus and Giroux, New York.
60. Gallucci F., Bird H.R., Berardi C., et al. Symptoms of attention-deficit hyperactivity disorder in an Italian school sample: findings of a pilot study. J.Am. Acad. Child Adolesc. Psychiatry 1993, 32:1051-1058.
61. Gazzetta Ufficiale della Republica Italiana, No. 230, 3 October 2003.
62. Germinario E.A.P., Arcieri R., Bonati M., Zuddas A., Masi G., Vella S., Chiarotti F., Panei P. Attention-Deficit/Hyperactivity Disorder Drugs and Growth: An Italian Prospective Observational Study. Journal of Child and Adolescent Psychopharmacology 2013, 23(7):440-447. The Italian ADHD Regional Reference Centers.
63. Gogineni R.R., Fallon A.E., Rao N.R. International medical graduates in child and adolescent psychiatry: adaptation, training, and contributions. Child Adolesc. Psychiatr. Clin. N. Am. 2010, 19:833-853.
64. Goldman L., Genel M., Bezman R., et al. Diagnosis and treatment of attention Deficit/Hyperactivity disorder in children and adolescents. Council of Scientific Affairs, American Medical Association. J.Am. Med. Assoc. 1998, 279:1100-1107.
65. Golse B. Enfant de moins de six ans: hyperactivite. Arch. Pediatr. 2004, 406-409.
66. Gomes M., Palmini A., Barbirato F., Rohde L.A., Mattos P. Knowledge about attention-deficit/hyperactivity disorder in Brazil. J.Braz. Psychiatry 2007, 56(2):94-101.
67. Goodman R.D., Neves dos Santos D., Robatto Nunes A.P., Periera de Miranda D. Asurvey of child mental health problems in a predominantly Afro-Brazilian rural community. Soc. Psychiatry Psychiatr. Epidemiol. 2005, 40:11-17.
68. Green C., Chee K. Understanding A.D.H.D: a Parent's Guide to Attention Deficit Hyperactivity Disorder in Children 1997, Vermilion, London.
69. Green H., McGinnity A., Meltzer H., Ford T., Goodman R. Mental Health of Children and Young People, Great Britain 2005, Palgrave MacMillan, London.
70. Guareschi-Cazzullo A., Mazzini-Tomazzolli C. La syndrome Ipercinetica, Contributo Casistico ala sua Validita'Nosografica. Neuropsichiatr. Infant. Fasc. 1971, 118.
71. Hinshaw S. Attention Deficit Disorders and Hyperactivity in Children 1994, Sage, Thousand Oaks, CA.
72. Hinshaw S.P., Scheffler R.M. The ADHD Explosion: Myths, Medication, Money, and Today's Push for Performance 2014, Oxford University Press, Oxford.
73. Hinshaw S.P., Scheffler R.M., Fulton B.D., et al. International variation in treatment procedures for ADHD: social context and recent trends. Psychiatr. Serv. 2011, 62(5):459-464.
74. Hoffmann H. Der Sruwwelpeter 1845, (accessed January 2014). http://www.struwwelpeter.com/.
75. Holowenko H., Pashute K. ADHD in schools: a survey of prevalence and 'Coherence' across a local UK population. Educ. Psychol. Pract. 2000, 16(2):181-190.
76. Horton-Salway M. Repertoires of ADHD in UK newspaper media. Health: Interdiscip. J. Soc. Study Health Illn. Med. 2011, 15:533-550.
77. Horwitz A., Wakefield J. The Loss of Sadness 2007, Oxford University Press, New York.
78. Huss M., Holling H., Kurth B., Schlank R. How often are german children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals; results of the German Health and Examination Survey (KiGGS). Eur. Child Adolesc. Psychiatry 2008, 17(Suppl.1):52-58.
79. Kessler R.C., Adler L., Barkley R., Biederman J., et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am. J. Psychiatry 2006, 163:716-723.
80. Knellwolf A.L., Deligne J., Chiarotti F., Auleley G.R., Palmieri S., Boisgard C.B., Panei P., Autret-Leca E. Prevalence and patterns of methylphenidate use in French children and adolescents. Eur. J. Clin. Pharmacol. 2008, 64:311-317.
81. Kooij S.J.J., Bejorot S., Blackwell A., Caci H., Casas-Brugue M., Carpentier P.J., Edvinsson D., Fayyad J., Foeken K., Fitzgerald M., Gaillac V., Ginsberg Y., Henry C., Krause J., Lensing M.B., Manor I., Niederhofer H., Nunes-Filipe C., Ohlmeier M.D., Oswald P., Pallanti S., Pehlivanidis A., Ramos-Quiroga J.A., Rastam M., Ryffel-Rawak D., Stes S., Asherson P. European consensus statement on diagnosis and treatment of adult ADHD: the European network on adult ADHD. BMC Psychiatry 2010, 10:67.
82. Kutcher S., Aman M., Brooks S.J., Buitelaar J. International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behavior disorder (DBDS): clinical implications and treatment practice suggestions. Eur. Neuropsychopharmacol. 2004, 14(1):11-28.
83. Lafortune D., Meilleur D. Medically defining, screening, and treating conduct disorder: a French controversy. J.Child Fam. Stud. 2014, 23:728-737.
84. Le Heuzey M.F., Vergnaud S., Mouren M.C. Traitements medicaux de l'enfant hyperactif: a propos des deux nouvelles formes de methylphenidate commercialisees en France. Arch. Pediatr. 2006, 13:100-103.
85. Lecendreux M., Konofal E., Faraone S.V. Prevalence of attention deficit hyperactivity disorder and associated features among children in France. J.Atten. Disord. 2010, 15(6):516-524.
86. Lee I.L., Schachar R.J., Chen S.X., Ornstein T.J., Charach A., Barr C., Ickowicz A. Predictive validity of DSM-IV and ICD-10 criteria for ADHD and hyperkinetic disorder. J.Child Psychol. Psychiatry 2008, 49(1):70-77.
87. Lohse M.J., Muller-Oerlinghausen B. Psychopharmaka. Arzneiverordnungsreport 2009 Aktuelle Daten, Kosten Trends und Kommentare edn 2009, 767-810. Springer Medizin Verlag, Heidelberg. U. Schwabe, D. Paffrath (Eds.).
88. Lohse M., Lorenzen A., Muller-Oerlinghausen B. Psychopharmaka. Arzneiverordnungs-report 2008 2008, 773-817. Springer, Berlin. U. Schwabe, D. Paffrath (Eds.).
89. Malacrida C. Cold Comfort: Mothers, Professionals and Attention Deficit Disorder 2003, University of Toronto Press, Toronto.
90. Marchini L., Puzzo F., Pirella A., et al. Se non sta fermo solo in USA scatta la ricetta. Occhio Clin. Pediatr. 2000, 4:12-14.
91. Marzocchi G.M., Cornoldi C. Una Sala di Facile uso per la Rilevazione dei Comportamenti Problematici dei Bambini con Deficit di Attenzione e Iperattivita. Psicol. Clin. dello Svilupp. 2000, 4:43-63.
92. Mayes R., Bagwell C., Erkulwater J. Medicating Children: ADHD and Pediatric Mental Health 2009, Harvard University Press, Cambridge, MA.
93. McCarthy S., Wilton L., Murray M.L., Hodgkins P., Asherson P., Wong I.C.K. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatr. 2012, 12:78.
94. Mises R. Classification francaise de troubles mentaux de l'enfant et de l'adolescent - R - 2012 2012, Presses de l'ecole des hautes etudes en santé publique. fifth ed.
95. Misès R., Quemada N., Botbol M., et al. French classification for child and adolescent mental disorders. Psychopathology 2002, 35:176-180.
96. Moffitt T.E., Melchior M. Why does the worldwide prevalence of childhood attention deficit disorder matter?. Am. J. Psychiatry 2007, 164:256-258.
97. Mueller A.K., Fuermaier A.B., Koerts J., Tucha L. Stigma in attention deficit hyperactivity disorder. Atten. Deficit Hyperact. Disord. 2012, 4(3):101-114.
98. Mugnaini D., Masi G., Brovedani P., Chelazzi C., Matas M., Romagnoli C., Zuddas A. Teacher reports of ADHD symptoms in Italian children at the end of first grade. Eur. Psychiatry. 2006, 21:419-426.
99. National Institute for Clinical Excellence Methylphenidate, Atomoxetine and Dexamfetamine for the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents 2006, Technology Appraisal 98, NICE, London, Available at:. http://www.nice.org.uk/TA98.
100. National Institute for Clinical Excellence Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults 2008, NICE Clinical Guidelines, No. 72. National Collaborating Centre for Mental Health.
101. National Institute for Clinical Excellence Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults. NICE Clinical Guidelines, No. 72. National Collaborating Centre for Mental Health (UK) 2009, British Psychological Society (UK), Leicester (UK).
102. Nettleton S., Burrows R., O'Malley L. The mundane realities of the everyday lay use of the Internet for health and their consequences for media convergence. Sociol. Health Illn. 2005, 27(7):972-992.
103. Neumarker K. Kramer-Pullnow syndrome: a contribution on the life of Hans Kramer and Hans Pullnow. Hist. Psychiatry 2005, 16(4):435-451.
104. Orford E. Commentary: diagnosis needs tightening. Br. Med. J. 1998, 316:1594-1596.
105. Ortega F., Barros D., Climan L., et al. Ritalin in Brazil: Production, Discourse and Practices. Interface-Comunicacao Saude Educacao 2010, vol. 14(39):499-510.
106. Overmeyer S., Ebert D. Die hyperkinetische Storung im Jugend- und Erwachsenenalter. Dtsch. Arztebl. 1999, 96:1275-1278.
107. O'Leary K.D., Vivian D., Cornoldi C. Assessment and treatment of 'hyperactivity' in Italy and the United States. J.Clin. Child Psychol. 1984, 13:56-60.
108. O'Leary K.D., Vivian D., Nisi A. Hyperactivity in Italy. J.Abnorm. Child Psychol. 1985, 4:485-500.
109. Panei P., Addis A., Arcieri R., Chiarotti F., Knellwolf A.L., Panci C., Rocchi F., Vella S. Registro nazionale dell'ADHD (Attention Deficit Hyperactivity Disorder): primo anno di attivita (2007-2008) 2008, Istituto Superiore di Sanita, Rome.
110. Panei P., Arcieri R., Bonati M., Bugarini M., Didoni A., Germinario E. Safety of psychotropic drug prescribed for attention-deficit/hyperactivity disorder in Italy. Adverse Drug Reaction Bulletin 2010, 260:999-1002.
111. Parliamentary Office of Science and Technology Treating Problem Behavior in Children 1997, OST, London.
112. Phillips C.B. Medicine goes to school: teachers as sickness brokers for ADHD. PLOS Med. 2006, 3(4):182.
113. Pichot P., Guelfi J.D., Kroll J. French perspectives on DSM-III. International Perspectives on DSM-III. 1983, 155-173. American Psychiatric Press, Inc., Washington, D.C. R.L. Spitzer, J.B. Williams, A.E. Skodol (Eds.).
114. Polanczyk G., de Lima M.S., Horta B.L., Biederman J., Rohde L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am. J. Psychiatry 2007, 164:942-948.
115. Polanczyk G., Laranjiera R., Zaleski M., Pinsky I. ADHD in a representative sample of the Brazilian population: estimated prevalence and comparative adequacy of criteria between adolescents and adults according to item response theory. J.Methods Psychiatr. Res. 2010, 19(3):177-184.
116. Ponde M.P., Freire A.C.C. Prevalence of attention deficit hyperactivity disorder in schoolchildren in the city of Salvador Bahia, Brazil. Arq. Neuro-Psiquiatr. 2007, 65(2):240-244.
117. Prendergast M., Taylor E., Rapoport J.L., Bartko J., Donnelly M., Zametkin A., Ahearn M.B., Dunn G., Wieselberg H.M. The diagnosis of childhood hyperactivity. A U.S.-U.K. Cross-National study of DSM-III and ICD-9. J.Child Psychol. Psychiatry 1988, 29:289-300.
118. Reisman D. Health Tourism: Social Welfare through International Trade 2010, Edward Elgar Publishing, Northampton, MA.
119. Remschmidt H., The Global ADHD Working Group Global ADHD Working Group. 2005. "Global consensus on ADHD/HKD.". Eur. Child Adolesc. Psychiatry 2005, 14:127-137.
120. Robison L., Sclar D., Skaer T., et al. National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children 1990-1995. Clin. Pediatr. 1999, 38:209-217.
121. Robison L.M., Sclar D.A., Skaer T.L., Galin R.S. Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99. Int. Clin. Psychopharmacol. 2004, 19:17-22.
122. Rohde L.A. ADHD in Brazil: the DSM-IV criteria in a culturally different population. J.Am. Acad. Child Adolesc. Psychiatry 2002, 41(9):1131-1133.
123. Sargeant J., Steinhausen H. European perspectives on hyperkinetic disorder. Eur. Child Adolesc. Psychiatry 1992, 1(1):34-41.
124. Scheffler R.M., Hinshaw S.P., Modrek S., Levine P. The global market for ADHD medication. Health Aff. 2007, 26(2):450-457.
125. Schubert I., Lehmkuhl G., Spengler A., Dopfner M., Ferber L. Methylphenidat bei hyperkinetischen Storungen. Verordnungen in den 90er-Jahren. Dtsch. Arztebl. 2001, 98:541-544.
126. Schubert I., Koster I., Lehmkuhl G. The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions. Dtsch. Arztebl. Int. 2010, 107(36):615-621.
127. Schwarz A. The Selling of Attention Deficit Disorder December 14 2013, 1. New York Times.
128. Schwarz A. Thousands of Toddlers are Medicated for A.D.H.D. May 16 2014, Report Finds, Raising Worries, New York Times, p. A11.
129. Sechter D. Enquête sur l'utilisation des classifications internationals (DSM III-R - CIM-10) en France, en psychiatrie libérale et publique. L'Encéphale, Vol. Spéc. 1995, 35-38.
130. Skounti M., Phialithis A., Galanakis E. Variations in prevalence of attention deficit disorder worldwide. Eur. J. Pediatr. 2007, 166:127-133.
131. Smith M. The uses and abuses of the history of hyperactivity. (De)constructing ADHD 2010, 21-40. Peter Lang, New York. L.J. Graham (Ed.).
132. Squillante M. Classifications in child and adolescent psychiatry. Arch. Psychiatr. Psychother. 2014, 1:15-19.
133. Swanson J.M., Sergeant J.A., Taylor E., et al. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998, 351:429-433.
134. Taylor E. Overactivity, hyperactivity and hyperkinesis: problems and prevalence. The Overactive Child: Clinics in Developmental Medicine. No. 97 1986, Blackwell, Oxford. E. Taylor (Ed.).
135. Taylor E. Syndromes of attention deficit and hyperactivity. Child and Adolescent Psychiatry: Modern Approaches 1994, 285-307. Blackwell Scientific Publications, Oxford. third ed. M. Rutter, E. Taylor, L. Hersov (Eds.).
136. Taylor E., Sergeant J., Dopfner M., Gunning B., Overmeyer S., Mobius H., Eisert H.G. Clinical guidelines for hyperkinetic disorder. Eur. Child Adolesc. Psychiatry 1998, 7:184-200.
137. Thapar A., Holmes J., Poulton K., Harrington R. Genetic basis of attention deficit and hyperactivity. Br. J. Psychiatry. 1999, 174:105-111.
138. Thomas K. Drug Makers Growth is Linked to Emerging Markets 2012, New York Times July 12.
139. Timimi S., Maitra B. ADHD and Globalization. Rethinking ADHD: From Brain to Culture 2009, 198-217. Palgrave Macmillan, New York. S. Timimi, J. Leo (Eds.).
140. Timimi S., et al. Acritique of the international consensus statement on ADHD. Clin. Child Fam. Psychol. Rev. 2004, 7(1):59-63.
141. Vallee M. Deconstructing America's Ritalin Epidemic: Contrasting US-France Ritalin Usage 2009, 265. (Ph.D. dissertation), University of California, Berkeley, 3410842.
142. Vallee M. Resisting American psychiatry: French opposition to DSM-III, biological reductionism, and the pharmaceutical ethos. Adv. Med. Sociol. 2011, 12:85-110.
143. Watters E. Crazy like Us: the Globalization of the American Psyche 2010, Free Press, New York.
144. Winterstein A.G., Gerhard T., Shuster J., Zito J., Johnson M., Liu H., Saidi A. Utilization of pharmacologic treatment in youth with attention/deficit/hyperactivity disorder in medicaid database. Ann. Pharmacother. 2008, 42(1):24-31.
145. Wittchen H.U., Jacobi F., Rehm J., Gustavsson A., Svensson M., Jonsson B., Olesen J., Allgulander C., Alonso J., Faravelli C., Fratiglioni L., Jennum P., Lieb R., Maercker A., van Os J., Preisig M., Salvador-Carulla L., Simon R., Steinhausen H.C. The size and burden of mental disorders and other disorders of the brain in Europe 2010. European Neuropsychopharmacology 2011, 21:655-679.
146. World Health Organization Atlas of Psychiatric Education and Training across the World 2005, (accessed September 2012). http://www.who.int/mental_health/evidence/Atlas_training_final.pdf.
147. Zisook S., Balon R., Bjorksten K., et al. Psychiatry residency training around the world. Acad. Psychiatry 2007, 31:309-325.
148. Zuddas A., Bonati M. Conferenza Nazionale di Consenso. Indicazioni e strategie terapeutiche per i bambini e gli adolescenti con disturbo da deficit attentivo e iperattivita' 2003, (URL accessed September 2012). http://www.aidaiassociazione.com/documents/ConsensusCaglRelaz.pdf.